@prefix rdf:	<http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix ns1:	<http://linked.opendata.cz/resource/drugbank/drug/> .
@prefix ns2:	<http://linked.opendata.cz/ontology/drugbank/> .
ns1:DB00043	rdf:type	ns2:Drug ;
	ns2:description	"A recombinant DNA-derived humanized IgG1k monoclonal antibody that selectively binds to human immunoglobulin E (IgE). Xolair is produced by a Chinese hamster ovary cell suspension culture in a nutrient medium containing the antibiotic gentamicin."@en ;
	ns2:dosage	<http://linked.opendata.cz/resource/drugbank/dosage/271B415F-363D-11E5-9242-09173F13E4C5> ,
		<http://linked.opendata.cz/resource/drugbank/dosage/271B4160-363D-11E5-9242-09173F13E4C5> ;
	ns2:generalReferences	"# Karagiannis SN, Wang Q, East N, Burke F, Riffard S, Bracher MG, Thompson RG, Durham SR, Schwartz LB, Balkwill FR, Gould HJ: Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cells. Eur J Immunol. 2003 Apr;33(4):1030-40. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12672069"@en ;
	ns2:group	"investigational"@en ,
		"approved"@en ;
	ns2:halfLife	"26 days"@en ;
	ns2:indication	"For treatment of asthma caused by allergies"@en .
@prefix owl:	<http://www.w3.org/2002/07/owl#> .
@prefix ns4:	<http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/> .
ns1:DB00043	owl:sameAs	ns4:DB00043 .
@prefix ns5:	<http://bio2rdf.org/drugbank:> .
ns1:DB00043	owl:sameAs	ns5:DB00043 .
@prefix dcterms:	<http://purl.org/dc/terms/> .
ns1:DB00043	dcterms:title	"Omalizumab"@en .
@prefix adms:	<http://www.w3.org/ns/adms#> .
@prefix ns8:	<http://linked.opendata.cz/resource/drugbank/drug/DB00043/identifier/drugbank/> .
ns1:DB00043	adms:identifier	ns8:DB00043 ,
		<http://linked.opendata.cz/resource/drugbank/drug/DB00043/identifier/national-drug-code-directory/50242-040-62> .
@prefix ns9:	<http://linked.opendata.cz/resource/drugbank/drug/DB00043/identifier/genbank/> .
ns1:DB00043	adms:identifier	ns9:J00228 .
@prefix ns10:	<http://linked.opendata.cz/resource/drugbank/drug/DB00043/identifier/uniprotkb/> .
ns1:DB00043	adms:identifier	ns10:P01857 .
@prefix ns11:	<http://linked.opendata.cz/resource/drugbank/drug/DB00043/identifier/wikipedia/> .
ns1:DB00043	adms:identifier	ns11:Omalizumab .
@prefix ns12:	<http://linked.opendata.cz/resource/drugbank/drug/DB00043/identifier/pharmgkb/> .
ns1:DB00043	adms:identifier	ns12:PA164752253 ;
	ns2:mechanismOfAction	"Xolair binds to IgE (a class of antibodies normally secreted in allergic responses), which prevents their binding to mast cells and basophils."@en ;
	ns2:packager	<http://linked.opendata.cz/resource/drugbank/company/271B415C-363D-11E5-9242-09173F13E4C5> ,
		<http://linked.opendata.cz/resource/drugbank/company/271B415D-363D-11E5-9242-09173F13E4C5> ;
	ns2:patent	<http://linked.opendata.cz/resource/drugbank/patent/1340233> ,
		<http://linked.opendata.cz/resource/drugbank/patent/2113813> ;
	ns2:routeOfElimination	"Liver elimination of IgG includes degradation in the liver reticuloendothelial system (RES) and endothelial cells. Intact IgG is also excreted in bile."@en ;
	ns2:synonym	"Ig gamma-1 chain C region"@en ;
	ns2:volumeOfDistribution	"* 78 \u00B1 32 mL/kg"@en .
@prefix ns13:	<http://linked.opendata.cz/ontology/sukl/drug/> .
ns1:DB00043	ns13:hasAHFSCode	<http://linked.opendata.cz/resource/AHFS/48-92-00> .
@prefix ns14:	<http://linked.opendata.cz/ontology/mesh/> .
@prefix ns15:	<http://linked.opendata.cz/resource/mesh/concept/> .
ns1:DB00043	ns14:hasConcept	ns15:M0387411 .
@prefix foaf:	<http://xmlns.com/foaf/0.1/> .
ns1:DB00043	foaf:page	<http://www.rxlist.com/cgi/generic/xolair.htm> ,
		<http://www.drugs.com/cdi/omalizumab.html> ;
	ns2:Molecular-Formula	<http://linked.opendata.cz/resource/drugbank/property/271B4165-363D-11E5-9242-09173F13E4C5> ;
	ns2:Molecular-Weight	<http://linked.opendata.cz/resource/drugbank/property/271B4164-363D-11E5-9242-09173F13E4C5> .
@prefix ns17:	<http://linked.opendata.cz/resource/atc/> .
ns1:DB00043	ns13:hasATCCode	ns17:R03DX05 ;
	ns2:affectedOrganism	"Humans and other mammals"@en ;
	ns2:casRegistryNumber	"242138-07-4"@en ;
	ns2:category	"       "@en ;
	ns2:containedIn	<http://linked.opendata.cz/resource/drugbank/medicinal-product/271B415E-363D-11E5-9242-09173F13E4C5> ;
	ns2:Hydrophobicity	<http://linked.opendata.cz/resource/drugbank/property/271B4162-363D-11E5-9242-09173F13E4C5> ;
	ns2:Isoelectric-Point	<http://linked.opendata.cz/resource/drugbank/property/271B4163-363D-11E5-9242-09173F13E4C5> ;
	ns2:Melting-Point	<http://linked.opendata.cz/resource/drugbank/property/271B4161-363D-11E5-9242-09173F13E4C5> .